The San Francisco-based provider of cloud-based service revenue management technology forecast adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) above $2.5 million for the three months ended Sept. 30 with revenue seen exceeding $49 million.
For the full year, the company now expects revenue above $195 million, better than its prior projection for revenue ranging from $190 million to $192 million.
The current average estimates of analysts polled by Thomson Reuters are revenue of $46.1 million in the September quarter and $191.9 million for the year. The company's prior forecast was for adjusted EBITDA of between $500,000 and $1 million, and revenue of $45 million to $46 million.ServiceSource also said it expects net income and non-GAAP earnings per share to come in above its previous guidance for a net loss of $4.5 million to $5 million and non-GAAP results of between breakeven and a loss of a penny per share. The stock was last quoted at $15, up 12.4%, on volume of more than 100,000, according to Nasdaq.com. Wall Street was bullish on ServiceSource ahead of the news with nine of the 10 analysts covering the stock at either strong buy (3) or buy (6). ServiceSource went public in late March, selling nearly 12 million shares at $10 each. The stock reached a high of $23.60 on June 30.
IlluminaIllumina (ILMN) was the big loser in the extended sesssion, dropping more than 20% after the San Diego life science technology developer said its third-quarter revenue would come in well below Wall Street expectations and suspended its outlook for the rest of the year. The company said it now sees revenue of $235 million for the September-ended quarter vs. the average analysts' view for revenue of $278 million. Illumina attributed the shortfall to delays in customer purchases because of the uncertain economy, excess capacity created by a new product launch in the second quarter, a drop in reagent usage for its Genome Analyzer installed customer base, and lower than expected upgrades to its HiSeq 2000 systems.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV